Rhythm Pharmaceuticals, Inc (RYTM) Stock Price

89.68 ▲ +1.30 (+1.47%)
Open: 93.745 Vol: 17.71K Day's range: 89.14 - 97.12 Jun 15, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
RYTM Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 89.76▼ 90.60▼ 91.26▼ 87.86▲ 88.12▲
MA10 89.83▼ 92.06▼ 91.15▼ 86.83▲ 88.15▲
MA20 90.37▼ 91.32▼ 89.58▲ 88.07▲ 89.53▲
MA50 91.78▼ 89.15▲ 88.04▲ 87.89▲ 96.58▼
MA100 91.92▼ 88.13▲ 88.22▲ 91.53▼ 76.11▲
MA200 90.13▼ 88.38▲ 89.83▼ 97.91▼ 52.95▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.001▲ -0.473▼ -0.024▼ 0.083▲ 0.152▲
RSI 39.754▼ 45.328▼ 50.708▲ 53.172▲ 48.666▼
STOCH 30.058     13.571▼ 43.525     42.375     51.268    
WILL %R -79.231▼ -81.400▼ -79.957▼ -52.284     -40.486    
CCI -86.164     -97.011     -26.615     134.055▲ 105.521▲
Latest Filters Detected On RYTM
▲ PSAR&MOM $RYTM PSAR Switch Up + Momentum Set Alert
▲ MACD $RYTM MACD(12,26,9) Crossed Above Signal Line Set Alert
MA $RYTM Price Crossed Above MA(26) Set Alert
▲ GAP $RYTM Open Gap Up %5 Set Alert
▲ GAP $RYTM Open Gap Up %3 Set Alert
▲ GAP $RYTM Open Gap Up %2 Set Alert
Rhythm Pharmaceuticals, Inc News
Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026
Saturday, June 13, 2026 05:41 AM
Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat mass with preservation of lean mass, and improvements in ...
Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome
Friday, June 12, 2026 01:20 PM
Most common adverse reactions (incidence ≥20% in at least 1 indication) included skin hyperpigmentation, injection site reactions, nausea, headache, diarrhea, abdominal pain, vomiting, depression, and ...
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Thursday, May 07, 2026 05:00 PM
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
RYTM historical stock data
date open high low close volume
15/06/26 93.745 97.12 89.05 89.68 2,128,901
12/06/26 87.65 90.16 87.65 88.38 549,662
11/06/26 86.46 89.08 84.90 87.66 672,245
10/06/26 87.88 92.35 85.57 85.71 837,412
09/06/26 87.65 90.14 84.73 87.86 599,562
08/06/26 87.09 87.1013 84.88 85.925 489,278
05/06/26 87.74 89.325 85.52 86.40 391,551
04/06/26 85.36 89.13 85.05 87.61 389,218
03/06/26 84.29 85.94 83.89 84.71 408,888
02/06/26 85.6066 86.64 82.89 84.35 518,796
Quote Details
52wk Low:60.80
52wk High:122.20
Vol:17.71K
Avg Vol(3m):11.4M
1Y Chng:+34.01%
1M Chng:+4.79%
Add to Watch List
More Information
Index US Composite
Market Cap. 6.12B